Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
7(64%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
9%
Ph not_applicable
2
18%
Ph phase_1
1
9%
Ph early_phase_1
1
9%
Ph phase_4
3
27%
Ph phase_3
3
27%

Phase Distribution

2

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
3(27.3%)
Phase 4Post-market surveillance
3(27.3%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

11

all time

Status Distribution
Active(8)
Completed(2)
Other(1)

Detailed Status

Recruiting6
Completed2
Active, not recruiting1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
7
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (9.1%)
Phase 11 (9.1%)
Phase 21 (9.1%)
Phase 33 (27.3%)
Phase 43 (27.3%)
N/A2 (18.2%)

Trials by Status

completed218%
recruiting655%
active_not_recruiting19%
not_yet_recruiting19%
unknown19%

Recent Activity

7 active trials
Showing 5 of 11
recruitingphase_3

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

NCT05603104
recruitingphase_3

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

NCT05973851
recruitingphase_4

Immunoinflammatory Regulation of Esketamine in Septic Patients

NCT04843982
not_yet_recruitingphase_4

Efficacy and Safety of S-ketamine in Elderly Patients Undergoing Non-cardiac Surgery: a RCT（ESSENCE）

NCT07063108
recruitingphase_3

Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study

NCT06161805
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05603104Phase 3

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

Recruiting
NCT05973851Phase 3

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Recruiting
NCT04843982Phase 4

Immunoinflammatory Regulation of Esketamine in Septic Patients

Recruiting
NCT07063108Phase 4

Efficacy and Safety of S-ketamine in Elderly Patients Undergoing Non-cardiac Surgery: a RCT（ESSENCE）

Not Yet Recruiting
NCT06161805Phase 3

Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study

Recruiting
NCT06199700Early Phase 1

Esketamine for the Treatment of Rett Syndrome

Active Not Recruiting
NCT06744361Phase 2

Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

Recruiting
NCT06579937Phase 4

Effects of Esketamine on Postoperative Behavioral Changes in Children Undergoing Tonsillectomy and/or Adenoidectomy

Recruiting
NCT06199011Not Applicable

Effect of Esketamine on Depressive Symptoms of Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy

Unknown
NCT01394757Not Applicable

Network Dysfunction, Schizophrenia and Pharmacological Magnetic Resonance Imaging (phMRI)

Completed
NCT00847418Phase 1

Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11